Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
HEAL.CNthis companyRestart Life Sciences Corp.	CA$0.08	-3.13×	3.29×	0×	-2.15×	-56.8%	0.0%	0.0%	0.0%	-108.0%	-87.8%	-16.9%	0.19×	1.01×	0×	3.67×	0.0%	3	-42.67	2	C
CVGR.CNCity View Green Holdings Inc.	CA$0.03	-2.81×	-1.81×	0×	-2.47×	-138.9%	0.0%	0.0%	0.0%	64.2%	75.8%	-14.3%	-0.02×	-0.02×	0×	0.01×	0.0%	2	-153.88	2	C
KNE.VKane Biotech Inc.	CA$0.03	-2.38×	-8.69×	15.17×	-2.68×	-157.1%	-38.2%	-727.4%	-636.0%	364.5%	-192.2%	-50.2%	-3.09×	-0.48×	-12.82×	0.68×	0.0%	3	-28.19	2	C
MOOD.CNDoseology Sciences Inc.	CA$0.10	-10.8×	3.46×	113.73×	-7.23×	66.3%	44.4%	-1108.2%	-1052.2%	-32.0%	-33.7%	-7.1%	0×	3.03×	0×	15.85×	0.0%	2	-6.32	—	—
RVV.CNRevive Therapeutics Ltd.	CA$0.02	-12.5×	-3.24×	0×	-12.34×	-98.9%	0.0%	0.0%	0.0%	25.5%	26.8%	-1.2%	0×	0.01×	-91.54×	0.04×	0.0%	3	-414.75	2	C
Peer median	—	-6.81×	-2.52×	7.58×	-4.95×	-118.9%	0.0%	-363.7%	-318.0%	44.8%	-3.5%	-10.7%	-0.01×	-0.01×	-6.41×	0.36×	0.0%	3	-91.03	2	—